P3 Health Partners Inc
NASDAQ:PIII
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P3 Health Partners Inc
NASDAQ:PIII
|
US |
|
S
|
Square Enix Holdings Co Ltd
XBER:EI4
|
JP |
|
Aerovate Therapeutics Inc
NASDAQ:AVTE
|
US |
|
Inseego Corp
NASDAQ:INSG
|
US |
Wall Street
Price Targets
PIII Price Targets Summary
P3 Health Partners Inc
According to Wall Street analysts, the average 1-year price target for
PIII
is 10.71 USD
with a low forecast of 8.08 USD and a high forecast of 13.13 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PIII's stock price target?
Price Target
10.71
USD
According to Wall Street analysts, the average 1-year price target for
PIII
is 10.71 USD
with a low forecast of 8.08 USD and a high forecast of 13.13 USD.
What is P3 Health Partners Inc's Revenue forecast?
Projected CAGR
6%
For the last 6 years the
compound annual growth rate for
P3 Health Partners Inc's revenue is
47%.
The projected
CAGR
for the next 2 years is
6%.